Jennifer Butler was appointed Executive Vice President and General Manager of Innate Pharma US Inc. on March 11 2019.
Prior to her appointment, Jennifer Butler served as Chief Business Officer, Chief Commercial Officer and Head of US operations, responsible for global business development and commercial strategy at Tessa Therapeutics, a clinical-stage oncology company. She previously served for more than 10 years in various commercial roles with increasing responsibility at AstraZeneca/MedImmune. While at AstraZeneca, she was the Global Commercial Head of Immuno-Oncology. Ms. Butler also previously worked in strategic healthcare consulting and as an analyst in Equity Capital Markets at Merrill Lynch.
Ms. Butler brings more than 20 years of strategic marketing and commercial leadership expertise across several therapeutic areas.